These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25040885)

  • 21. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
    Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma?
    Schipmann S; Schwake M; Sporns PB; Voß KM; Sicking J; Spille DC; Hess K; Paulus W; Stummer W; Brokinkel B
    World Neurosurg; 2018 Nov; 119():e589-e597. PubMed ID: 30081236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
    Winther TL; Torp SH
    J Neurooncol; 2017 Feb; 131(3):575-583. PubMed ID: 27868157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas.
    Takahashi JA; Ueba T; Hashimoto N; Nakashima Y; Katsuki N
    Surg Neurol; 2004 Feb; 61(2):149-55; discussion 155-6. PubMed ID: 14751627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
    Voß KM; Spille DC; Sauerland C; Suero Molina E; Brokinkel C; Paulus W; Stummer W; Holling M; Jeibmann A; Brokinkel B
    J Neurooncol; 2017 Jul; 133(3):641-651. PubMed ID: 28527009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
    Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
    Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World Health Organization Grade I Convexity Meningiomas: Study on Outcomes, Complications and Recurrence Rates.
    Nanda A; Bir SC; Konar S; Maiti TK; Bollam P
    World Neurosurg; 2016 May; 89():620-627.e2. PubMed ID: 26704204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
    Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
    Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification.
    Spille DC; Hess K; Bormann E; Sauerland C; Brokinkel C; Warneke N; Mawrin C; Paulus W; Stummer W; Brokinkel B
    J Neurosurg; 2021 Jun; 134(6):1764-1771. PubMed ID: 32679565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence.
    Nanda A; Bir SC; Konar S; Maiti T; Kalakoti P; Jacobsohn JA; Guthikonda B
    J Clin Neurosci; 2016 Sep; 31():112-21. PubMed ID: 27427214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pSlug
    Woo CG; Son SM; Kim EG; Lee OJ
    Int J Surg Pathol; 2023 Sep; 31(6):1021-1026. PubMed ID: 36172742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between phosphorylated Histone H3 (PHH3) and p-STAT3 in Meningiomas.
    Ozek E; Akdag H; Tosuner Z; Abdallah A; Hatiboglu MA
    Clin Neurol Neurosurg; 2019 Mar; 178():46-50. PubMed ID: 30710729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resected WHO grade I meningioma and predictors of local control.
    Nowak-Choi K; Palmer JD; Casey J; Chitale A; Kalchman I; Buss E; Keith SW; Hegarty SE; Curtis M; Solomides C; Shi W; Judy K; Andrews DW; Farrell C; Werner-Wasik M
    J Neurooncol; 2021 Mar; 152(1):145-151. PubMed ID: 33420897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
    Gousias K; Schramm J; Simon M
    J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
    Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
    World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas.
    Otero-Rodriguez A; Tabernero MD; Munoz-Martin MC; Sousa P; Orfao A; Pascual-Argente D; Gonzalez-Tablas M; Ruiz-Martin L
    World Neurosurg; 2016 Dec; 96():483-488. PubMed ID: 27637164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin predicts the behaviour of atypical meningioma.
    Lin CK; Tsai WC; Lin YC; Hueng DY
    Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.